β-adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Dobson Jr , James G ^a   Shea, Lynne G ^a   Fenton, Richard A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Adenosine; Adenosine A1 receptor; Alkaline phosphatase; Catecholamines; Protein kinase A

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENYLATE CYCLASE; ALKALINE PHOSPHATASE; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; PHOSPHORUS 32;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MEMBRANE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0141565391     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00950.2002     Document Type: Article

References (31)

1. Beavo JA, Bechtel PJ, and Krebs EG. Preparation of homogenous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle. Methods Enzymol 38: 299-308, 1974.
2. Chakrabarti S, Wang L, Tang WJ, and Gintzler AR. Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol Pharmacol 54: 949-953, 1998.
3. s stimulation. Proc Natl Acad Sci USA 94: 14100-14104, 1997.
4. Dobson JG Jr. Protein kinase regulation of cardiac phosphorylase activity and contractility. Am J Physiol Heart Circ Physiol 234: H638-H645, 1978.
5. Dobson JG Jr. Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3′,5′-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res 43: 785-792, 1978.
6. Dobson JG Jr. Mechanism of adenosine inhibition of catecholamine-induced elicited responses in heart. Circ Res 52: 151-160, 1983.
7. Dobson JG Jr and Fenton RA. Antiadrenergic effects of adenosine in the heart. In: Regulatory Function of Adenosine, edited by Berne RM, Rall TW, and Rubio R. Boston, MA: Nijhoff, 1983, p. 363-376.
8. Dobson JG Jr, Ordway RW, and Fenton RA. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol Heart Circ Physiol 251: H455-H462, 1986.
9. Dobson JG Jr, Fenton RA, and Romano FD. Increased myocardial adenosine production and reduction of β-adrenergic contractile response in aged hearts. Circ Res 66: 1381-1390, 1990.
10. Espinasse I, Iourgenko V, Defer N, Samson F, Hanoune J, and Mercadier JJ. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity. J Mol Cell Cardiol 27: 1789-1795, 1995.
11. Fenton RA and Dobson JG Jr. Adenosine and calcium alter adrenergic-induced intact heart protein phosphorylation. Am J Physiol Heart Circ Physiol 246: H559-H565, 1984.
12. Fenton RA and Dobson JG Jr. Hypoxia enhances isoproterenol-induced increase in heart interstitial adenosine depressing β-adrenergic contractile responses. Circ Res 72: 571-578, 1993.
13. Fenton RA, Tsimikas S, and Dobson JG Jr. Influence of β-adrenergic stimulation and contraction frequency on heart interstitial adenosine. Circ Res 66: 457-468, 1990.
14. George EE, Romano FD, and Dobson JG Jr. Adenosine and acetylcholine reduce isoproterenol-induced protein phosphorylation of rat myocytes. J Mol Cell Cardiol 23: 749-764, 1991.
15. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, and Mische SM. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20: 601-605, 1999.
16. Hazeki O and Ui M. Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem 256: 2856-2862, 1981.
17. Ishikawa Y and Homcy CJ. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res 80: 297-304, 1997.
18. Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ, and Ishikawa Y. Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 270: 12481-12484, 1995.
19. Krupinski J, Coussen F, Bakalyar HA, Tang WJ, Feinstein PG, Orth K, Slaughter C, Reed RR, and Gilman AG. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science 244: 1558-1564, 1989.
20. LaMonica DA, Frohloff N, and Dobson JG Jr. Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol Heart Circ Physiol 248: H737-H744, 1985.
21. Pleuffer E, Dreher RM, Metzger H, and Pleuffer T. Catalytic unit of adenylate cyclase: purification and identification by affinity crosslinking. Proc Natl Acad Sci USA 82: 3086-3090, 1985.
22. s in heterologous desensitization: a role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology 131: 2774-2784, 1992.
23. Romano FD and Dobson JG Jr. Adenosine modulates β-adrenergic signal transduction in guinea pig heart ventricular membranes. J Mol Cell Cardiol 22: 1359-1370, 1990.
24. i agonist, phenylisopropyladenosine, reduces high affinity isoproterenol binding to the β-adrenergic receptor of rat myocardial membranes. Second Messengers Phosphoproteins 12: 29-43, 1988.
25. Romano FD, Macdonald SG, and Dobson JG Jr. Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol Heart Circ Physiol 257: H1088-H1095, 1989.
26. Schrader J, Baumann G, and Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch 372: 29-35, 1977.
27. Simonis G, Weinbrenner C, and Strasser RH. Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase. Basic Res Cardiol 98: 104-113, 2003.
28. Taussig R and Gilman AG. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270: 1-4, 1995.
29. Tobise K, Ishikawa Y, Holmer SR, Im MJ, Newell JB, Yoshie H, Fujita M, Susannie EE, and Homcy CJ. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle. Circ Res 74: 596-603, 1994.
30. Watson PA, Krupinski J, Kempinski AM, and Frankenfield CD. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J Biol Chem 269: 28893-28898, 1994.
31. Yoshimura M and Cooper DM. Type-specific stimulation of adenylyl cyclase by protein kinase C. J Biol Chem 268: 4604-4607, 1993.